<DOC>
	<DOCNO>NCT00013806</DOCNO>
	<brief_summary>131I-metaiodobenzylguanidine ( 131I-MIBG ) norepinephrine analog concentrate adrenergic tissue therefore hold promise cell-specific treatment neuroblastoma . This dual institution , Phase II study 131I-MIBG administer previously define maximum practical dose 18 mCi/kg child relapse refractory neuroblastoma .</brief_summary>
	<brief_title>CHP677 : I-Metaiodobenzylguanidine ( I-MIBG ) Therapy Refractory Neuroblastoma : Phase II Study</brief_title>
	<detailed_description />
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>3-Iodobenzylguanidine</mesh_term>
	<criteria>Inclusion criterion : Refractory neuroblastoma original diagnosis base tumor histopathology elevate urine VMA typical tumor cell bone marrow .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>Relapsed refractory neuroblastoma</keyword>
</DOC>